Form D · Other Health Care
ENABLE INJECTIONS, INC
Cincinnati, OH · CIK 0001619825
Offering snapshot reported Jan 9, 2026 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Dec 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 9, 2026 | Initial | $29,999,997 | No comparison | 1 | SEC filing |
| Feb 3, 2022 | Initial | $150,044,600 | No comparison | 22 | SEC filing |
| Oct 30, 2018 | Initial | $30,670,823 | No comparison | 15 | SEC filing |
| Nov 17, 2016 | Amendment | $25,000,000 | $15,000,000vs Sep 1, 2016 | 1 | SEC filing |
| Sep 1, 2016 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Aug 24, 2016 | Initial | $22,925 | No comparison | 1 | SEC filing |
| Aug 22, 2016 | Initial | $2,000,000 | No comparison | 13 | SEC filing |
| Aug 17, 2016 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Aug 17, 2016 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Aug 17, 2016 | Amendment | $247,250 | $0vs Aug 11, 2016 | 0 | SEC filing |
| Aug 17, 2016 | Amendment | $5,000,000 | $0vs Aug 2, 2016 | 19 | SEC filing |
| Aug 11, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 11, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 11, 2016 | Initial | $247,250 | No comparison | 0 | SEC filing |
| Aug 2, 2016 | Initial | $5,000,000 | No comparison | 19 | SEC filing |
| Apr 18, 2016 | Amendment | $2,000,000 | $0vs Sep 18, 2014 | 13 | SEC filing |
| Sep 18, 2014 | Initial | $2,000,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-569420
Source: Form D, filed Jan 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vickie Capps | Director |
| Mark A. Collar | Director |
| Jim Collins | Director |
| Richard J. D'augustine | Director |
| John De Ford | Director |
| Erik Falk | Director |
| Timothy Flaherty | Executive |
| Michael D. Hooven | Director, Executive |
| Matt Huddleston | Executive |
| David Kroekel | Executive |
| John Rice | Director |
| Karen Robards | Director |
| Beckie Robertson | Director |
| Nigel Sheail | Director |
| Simone Song | Director |
| Susan Spies | Executive |
| Daniel Von Allmen | Director |
| Norman R. Weldon | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2863 East Sharon Road
Cincinnati, OH, 45241
Cincinnati, OH, 45241